AP

Avinash Pratap Singh

Active Director Director DIN 10093372
DIN 10093372 First appointment Mar 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Avinash Pratap Singh

Data last updated:

Avinash Pratap Singh is a Director at Nsh Pharmaceutics India Private Limited (since 2023). Nsh Pharmaceutics India Private Limited reported revenue of ₹39.6 Lakh (FY 2025).

DIN 10093372
Primary Designation Director
First Appointment 29 Mar 2023
Oldest Company Age 3 yrs
Largest company Nsh Pharmaceutics India Private Limited · ₹39.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Mar 20232023₹39.6 Lakh (FY 2025)Active

Board colleagues of Avinash Pratap Singh

NameDINCompanyDesignation
Ashish Kumar07021175Nsh Pharmaceutics India Private LimitedDirector

Directorship timeline

Open interactive timeline →
Nsh Pharmaceutics India Private Limited
Premium access

Shareholding and investment profile for Avinash Pratap Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avinash Pratap Singh

Avinash Pratap Singh currently holds 1 directorship: Nsh Pharmaceutics India Private Limited (Director, since 29 Mar 2023, revenue ₹39.6 Lakh (FY 2025)).

Avinash Pratap Singh was first appointed on 29 Mar 2023 as Director at Nsh Pharmaceutics India Private Limited.

The current boards of Avinash Pratap Singh's companies include Ashish Kumar (Nsh Pharmaceutics India Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available